Receptor-mediated endocytosis of tissue-type plasminogen activator (t-PA) by liver cells

Thrombosis Research. Supplement
D C RijkenT J van Berkel

Abstract

Tissue-type plasminogen activator (t-PA) has a short half-life in the circulation because the enzyme is rapidly cleared by the liver. This short review summarizes recent literature concerning mechanisms of uptake and degradation of t-PA in the liver. In vivo studies in rats show that degradation takes place via a lysosomal pathway. Saturation of the uptake system at high t-PA concentrations suggests a receptor-mediated mechanism. Competition experiments with various glycoproteins indicate that the asialoglycoprotein receptor is not involved, but they point to a role for the mannose receptor, which recognizes t-PA via its high mannose-type oligosaccharide on the first kringle domain. Both in vivo and in vitro studies with isolated liver cells demonstrate that parenchymal cells, as well as liver endothelial cells, are involved in the clearance of t-PA. Parenchymal cells, as the hepatoma cell line Hep G2, endocytose t-PA via a still unknown, possibly t-PA specific receptor, while liver endothelial cells catabolize t-PA via the mannose receptor.

References

Dec 1, 1987·The Journal of Clinical Investigation·K A HajjarR L Nachman
Jul 1, 1988·Thrombosis Research·D P Beebe, D L Aronson
Aug 15, 1985·Thrombosis Research·S NilssonC Mattsson
Sep 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·T NyB Lund

❮ Previous
Next ❯

Citations

Oct 20, 2005·The British Journal of Ophthalmology·R C Tripathi, B J Tripathi
Oct 1, 1991·The Journal of Clinical Investigation·J D VassalliD Belin
Feb 20, 2010·PLoS Pathogens·Aaron K Neumann, Ken Jacobson
Aug 21, 2001·The Journal of Investigative Dermatology·G SzolnokyL Kemény
Aug 22, 2012·Journal of Thrombosis and Haemostasis : JTH·D C RijkenF W G Leebeek
Jul 1, 1993·Thrombosis Research·T NyM Ohlsson
Mar 8, 2006·Seminars in Fetal & Neonatal Medicine·Courtney Thornburg, Steven Pipe
Jul 1, 1992·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M OtterD C Rijken
May 8, 2009·Biological & Pharmaceutical Bulletin·Nana KawasakiTeruhide Yamaguchi
Sep 29, 2020·Frontiers in Physiology·Alex L WilkinsonShishir Shetty
Nov 5, 2019·Molecular Biology Reports·Reza NedaeiniaMaryam Ranjbar
Sep 24, 2021·Seminars in Liver Disease·Daniel A PattenShishir Shetty

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.